Navigation Links
Herley Industries, Inc. Reports Third Quarter Earnings
Date:6/11/2009

ctors and pricing pressures, changes in legal and regulatory requirements, cancellation or deferral of customer orders, technological change or difficulties, difficulties in the timely development of new products, difficulties in manufacturing, commercialization and trade difficulties and current economic conditions, including the potential for significant changes in US defense spending under the new Administration which could affect future funding of programs and allocations within the budget to various programs as well as the factors set forth in this report and in our public filings with the Securities and Exchange Commission.


                     HERLEY INDUSTRIES, INC. AND SUBSIDIARIES
                       CONDENSED CONSOLIDATED BALANCE SHEETS
                         (In thousands, except share data)

                                                   May 3,
                                                    2009            August 3,
                                                (Unaudited)           2008
                                                 ---------         --------

    ASSETS
    Current Assets:
      Cash and cash equivalents                   $14,139           $14,347
      Trade accounts receivable, net               27,427            27,003
      Income Taxes Receivable                           -             2,056
      Costs incurred and income recognized
       in excess of billings on uncompleted
       contracts and claims                        15,013            19,490
      Other receivables                             1,169             1,286
      Inventories, net                             67,261            61,559
      Deferred income taxes                        16,364            11,263
      Other current assets                          2,171             1,276
                                                 --------          --------
        Total Current Assets               
'/>"/>
SOURCE Herley Industries, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Herley Reports 4th Quarter and Year-End Results
2. Herley Industries, Inc. Receives a $5 Million Award from EDO for Electronic Components for IEDs
3. Herley Industries Announces the Passing of Its Former President
4. Herley Industries, Inc. Second Quarter Earnings Release and Conference Call Notice
5. Herley Reports Second Quarter Results
6. Herley Awarded $1 Million in Awards for Integrated Microwave Assemblies for U.S. Military Aircraft
7. Herley Announces Settlement Agreement with U.S. Government
8. Herley Reports Third Quarter Results
9. Herley Industries, Inc. Engages Jefferies Quarterdeck to Explore Strategic Alternatives
10. Herley New England Receives Additional $1.3 Million Contract Award from Lockheed Martin for the Multi-Mission Helicopter
11. Herley Industries, Inc. First Quarter Earnings Release and Conference Call Notice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... A jury of 8 people in the W...unty woman $2,300,000 in pain and suffering for a ...y, James Tallman and Alicia Nocera of Thomas E. Cr...lf of the plaintiff, Vita Monestersky and against ...emergency total abdominal hysterectomy at age 18. ...
(Date:11/8/2009)..., Nation,s largest network of Hispanic health ad...are reform in 2009 ,, WASHINGTON, Nov. 7 /PRNe...epresentatives showed they have heard the voice of...th Care for America Act. Now the Senate must deliv...alth care reform," said Dr. Jane L. Delgado, Presi...
(Date:11/8/2009)..., Calls for Swift Passage of H.R. 3961 to Secure... Statement Attributable ...ical Association. ,, (Logo: http://www.newsco... AMA hails the passage of the House health reform ...r patients and physicians and calls for swift pass...
(Date:11/8/2009)..., Health Care Vote Shows Who Sides With Working ..., Pa., Nov. 8 On the he... Representatives for a good, balanced health care ... scoring of how our state,s U.S. representatives v...erica Act. ,, The legislation, which passed Sa...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 K...h Insurance Plans (AHIP), released the following s..., "Health plans strongly support comprehensive hea...iscussion by proposing a complete overhaul of how ...e proposed guaranteed coverage, elimination of pre...
Breaking Medicine News(10 mins):Health News:Pennsylvania Jury Awards $2.3 Million to Fayette County Woman in Medical Malpractice Case 2Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2
...headache stimuli also affect the appetite centre o...y loss of appetite often accompanies pain. People ...it is often assumed this must be because one commo...in the brain when pain takes away your appetite. F...
...nt risk factor for most cancers, says a Stanford U...ccur early in life are more likely to have a genet...re thyroid and testicular cancers, are even more l...re genes. The new model led him to a very ...
...cancer, a single raw clove of garlic can do wonde... Garlic is best known for staying off heart disea.... A substance called diallyl disulfide in garlic ...fide to rats and found it increased levels of the ...
...metimes.There has been a rise in the number of saf...heart rhythm. Many depend on either a pacemak...eart beating rhythimically. However sophisticated ...ings on heart devices issued by the Food and Drug ...
... have a common side effect- cough. Iron supplement...people on a widely-used blood pressure medication....ibitors are often used to treat high blood pressur...rious by doctors, but it is the most common reason...
...smaller babies tend to have lower IQs.While the di...ificance they might be of importance at a populati...ity have examined over 2500 children at age seven ...le factors such as the mother's age, race, educati...
Other Medicine News:
(Date:11/6/2009)...O, Nov. 6 Ardea Bioscien...y focused on the development of small-molecule the...man immunodeficiency virus (HIV), today reported r...e third quarter and nine months ended September 30...-bin/prnh/20091104/ARDEALOGO ) ,, "Since our la...
(Date:11/6/2009)... Nov. 6 GeoVax Labs, In...ompany"), an Atlanta-based, biopharmaceutical comp...by HIV-1 (Human Immunodeficiency Virus) and other ...er 2009 financial results and provided an operatio... and Chief Executive Officer commented, "We are pl...
(Date:11/6/2009)...S, November 6 , - Trial W...id for the,Treatment of Multi-Resistant Staphyloco...a speciality pharmaceutical company focused on the...signed to overcome the significant global,problem ...most advanced oral,antibacterial NXL103 (flopristi...
Breaking Medicine Technology:Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Lack of Good Sleep Might Be Deadly 48636 1Lack of Good Sleep Might Be Deadly 48636 2Lack of Good Sleep Might Be Deadly 48636 3GlobalEquityReport com Issues Cancer Stocks On The Move Today 3A HEB GNBT CTIC CTHP DNDN 48633 1GlobalEquityReport com Issues Cancer Stocks On The Move Today 3A HEB GNBT CTIC CTHP DNDN 48633 2Researchers at Case Western Reserve discover a new way the body fights fungal infection 48630 1Researchers at Case Western Reserve discover a new way the body fights fungal infection 48630 2
...sciences, Inc. (Nasdaq: RDEA ) today announced th...proof-of-concept monotherapy study of RDEA806,the ...erse transcriptase,inhibitor (NNRTI) for patients ...ing robust antiviral activity with a well-tolerate...ven today by Dr. Graeme Moyle, Director,of HIV Res...
...oteoTech),today announced that it has completed re...ts and has been cleared by the FDA to initiate its...ovel small molecule drug targeting,toxic beta-amyl...eimer,s,disease. ProteoTech initiated its Phase 1 ...ational Conference on Alzheimer,s disease in Chica...
Other Medicine Technology:Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference 2Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference 3Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference 4ProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease 2
9.00mm diameter Corneal Trephine Blades
8.75mm diameter Corneal Trephine Blades
8.25mm diameter Corneal Trephine Blades
7.50mm diameter Corneal Trephine Blades
Medicine Products: